Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.47 |
| ▸ | ALPI | P09923 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | XIAP | P98170 | 1/20 | 0.46 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | MPO | P05164 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histidine SCHEMBL28042776 | 1.00 | SLC7A5 (0.47) | SLC7A5ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL11052850 | 0.95 | SLC7A5 (0.43) | SLC7A5ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL28098393 | 0.91 | CYP1A2 (0.49) | SLC7A5ALPIPKMPTGS1XIAP | |
| Tyrosine SCHEMBL25286397 | 0.91 | SLC7A5 (0.60) | SLC7A5ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL29086897 | 0.90 | SLC7A5 (0.47) | SLC7A5ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL995910 | 0.89 | SLC7A5 (0.47) | SLC7A5ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL163442 | 0.89 | SLC7A5 (0.47) | SLC7A5ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL3259 | 0.89 | SLC7A5 (0.47) | SLC7A5ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL163443 | 0.89 | SLC7A5 (0.47) | SLC7A5ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL8080341 | 0.89 | SLC7A5 (0.47) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11045523-B2 | Formulation of growth hormone albumin-binder conjugate | NOVO NORDISK HEALTHCARE AG (CH) | 2021-06-29 | — | — | US | disclosed |
| EP-2981282-B1 | GROWTH HORMONE COMPOUND FORMULATION | NOVO NORDISK HEALTHCARE AG (CH) | 2020-11-04 | — | — | EP | disclosed |
| US-20160058879-A1 | Growth Hormone Compound Formulation | NOVO NORDISK HEALTHCARE AG (CH) | 2016-03-03 | — | — | US | disclosed |
| EP-2981282-A1 | GROWTH HORMONE COMPOUND FORMULATION | Novo Nordisk Health Care AG (CH) | 2016-02-10 | — | — | EP | disclosed |
| CN-105120887-A | Growth hormone compound formulation | NOVO NORDISK HEALTHCARE AG | 2015-12-02 | — | — | CN | disclosed |
| WO-2014166836-A1 | GROWTH HORMONE COMPOUND FORMULATION | NOVO NORDISK A/S (DK) | 2014-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11045523-B2 | Formulation of growth hormone albumin-binder conjugate | ALB, SHBG, SERPINA6 | SLC7A5 1230/4885ALPI 716/4885PKM 4353/4885 |
| US-20160058879-A1 | Growth Hormone Compound Formulation | GHRHR, GHSR, GHITM | SLC7A5 1048/4885ALPI 2781/4885PKM 2085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.